Circovirus

It’s one of the most devastating and economically damaging pig diseases in the world: Porcine circovirus associated disease (PCVAD). It can strike early or appear in a late form. And once it strikes, the consequences are never good.

Circovirus

BOEHRINGER INGELHEIM ANIMAL HEALTH SUPPORTS INDEPENDENT PCV2 RESEARCH

For the ninth time, Boehringer Ingelheim Animal Health has funded independent European research projects related to Porcine Circovirus Type 2 (PCV2) infection and associated diseases. Over the past nine years, 26 research projects have been awarded with € 25,000 each accumulating to € 650,000 in total.

Circovirus

PORCINE CIRCOVIRUS: FOCUS OF LATEST 'AT THE MEETING' SWINE HEALTH SERIES

US - In the latest 'At the Meeting' (ATM) audio program on swine health from the Morrison Group, leading swine veterinarians take on the historic and novel work regarding porcine circovirus (PCV2), including prevention, new diagnostic methods and vertical transmission’s impact on pig production and sow herds.

Circovirus

BOEHRINGER INGELHEIM SEES ADVANTAGES OF FRESHLY MIXED VACCINE

Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination. As a consequence of this decision, the company has discontinued its PCV2/M.hyo RTU research program.

Circovirus

BOEHRINGER INGELHEIM LAUNCHES 3FLEX 50 DOSES HSB VACCINE FOR SWINE

Boehringer Ingelheim Vetmedica, Inc., (BIVI) introduces the 3FLEX® 50 Doses HSB (head space bottle) vaccine for swine veterinarians and producers to control three of the most common respiratory diseases in pigs: porcine circovirus, "Mycoplasma hyopneumoniae" and porcine reproductive and respiratory syndrome (PRRS).